Autoantigens and Insulin Receptor in Type 1 Diabetes
Year: 2019
Type: article
Abstract: Type 1 diabetes (T1D) is a T cell mediated autoimmune disease that results in the destruction of insulin producing beta cells in the pancreas.This work involves understanding of the pathophysiology behind the initial T1D progression and development of an immunotherapy targeting the autoreactive T cells involved in the T1D autoimmunity.Previous findings have reported that the initial immune cell movement in the pancreas may not be due to T cell-MHC/Antigen specific interactions.Activated T cells express insulin receptor (IR) on the cell surface.Insulin binds the IR and modulates downstream events for cell survival, differentiation, growth, and motility/chemotaxis.IR + splenic T cells obtained from diabetic NOD mice, upon transfer into irradiated young NOD mice, caused insulitis and diabetes, while IR -T cells did neither.Our lab has developed an animal model, C57BL/6-CD3FLAGmIR.mfm,which shows CD3 + T cell trafficking to the pancreas without involvement of an antigen specific immune response.Instead, T cells from this transgenic mouse that overexpress FLAG tagged mouse insulin receptors (mIR) cause insulitis, abnormal glucose tolerance, and impaired glucose stimulated insulin release, without hyperglycemia.This study shows the effect of FLAG tagged mIR overexpressing T cell inflammation in the pancreas on the metabolic profile
Author: Nandedkar, Neha Dhananjay
Institution: University of Toledo
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7017558545
